1. Home
  2. News
  3. Shanghai MicuRx Pharmaceutical Co., Ltd.
  4. (688373)"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Report for Q3 2026
More Shanghai MicuRx Pharmaceutical Co., Ltd. news
Shanghai MicuRx Pharmaceutical Co., Ltd.SSE: 688373

(688373)"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Report for Q3 2026

Oct 29, 2026 · Issued by Shanghai MicuRx Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688373 · Oct 29, 2026 · 12 pages · Chinese

On 6ix: 6ix.com/news/688373shanghai-micurx-pharmaceutical-co-ltdreport-for-q3-2026

Shanghai MicuRx Pharmaceutical Co., Ltd. on 6ix

Earlier from Shanghai MicuRx Pharmaceutical

  • (688373)"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Signing of Authorization and License Agreement with ClearideBioOct 10
  • (688373)"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 30th Meeting of the 2nd Board of DirectorsOct 10
  • Announcement on Progress of Litigation Involving a U.S. SubsidiarySep 25
  • Announcement on Shareholding Reduction Plan of ShareholderSep 23
  • Announcement on Expiration of Shareholding Reduction Plan by Shareholder and Results of Shareholding ReductionSep 10

Later from Shanghai MicuRx Pharmaceutical

  • (688373)"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Attending the Q3 2026 Collective Performance Briefing of Listed Companies in Shanghai JurisdictionNov 4
All Shanghai MicuRx Pharmaceutical news releases↗

Follow Shanghai MicuRx Pharmaceutical into a list and get an email when it puts out news.

Follow Shanghai MicuRx Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer